<p>Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study</p>-Reference-Cited by-同舟云学术

Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study

Published:2020-08 Issue: Volume:Volume 14 Page:3315-3324
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Zare-Zardini Hadi^ORCID,Alemi Ashraf^ORCID,Taheri-Kafrani Asghar,Hosseini Seyed Ahmad,Soltaninejad Hossein,Hamidieh Amir Ali,Haghi Karamallah Mojtaba^ORCID,Farrokhifar Majid,Farrokhifar Mohammad

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference42 articles.

1. Molecular Pathways to Prostate Cancer

2. Anti-androgens and other hormonal therapies for prostate cancer

3. 20(S)-Ginsenoside Rh2 Induce the Apoptosis and Autophagy in U937 and K562 Cells

4. Ginsenoside Rh2 enhances the antitumor immunological response of a melanoma mice model

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenosides in cancer: Proliferation, metastasis, and drug resistance;Biomedicine & Pharmacotherapy;2024-08

2. Efficient PEGylated Dendrimer Nanoplatform for Codelivery of Hyaluronidase and Methotrexate: A New Frontier in Chemotherapeutic Efficacy and Tumor Penetration;ACS Applied Nano Materials;2024-07-18

3. Computer-driven formulation development of Ginsenoside Rh2 ternary solid dispersion;Drug Delivery and Translational Research;2024-06-24

4. The development of nanocarriers for natural products;WIREs Nanomedicine and Nanobiotechnology;2024-05

5. Cationic nanocarriers: A potential approach for targeting negatively charged cancer cell;Advances in Colloid and Interface Science;2024-05